Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 18, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Biotech
Biotech
Biotech
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
Life Sciences Times
-
August 18, 2026
Biotech
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
Life Sciences Times
-
August 18, 2026
Biotech
Enveda Reports Positive Phase 1 Results for ENV-308
Life Sciences Times
-
August 18, 2026
Biotech
Aizen Therapeutics Signs Oral Biologics Collaboration Worth Up to $100 Million Per Target
Life Sciences Times
-
August 17, 2026
Biotech
Hypertrophic Cardiomyopathy Market Reached $3.2 Billion in 2025, DelveInsight Says
Life Sciences Times
-
August 17, 2026
Biotech
Quanterix Q2 Revenue Rises 34% to $32.9 Million, Company Cuts 2026 Outlook
Life Sciences Times
-
August 10, 2026
0
Biotech
LifeMine Raises $263 Million to Advance Organ Transplant Drug LIFE-001
Life Sciences Times
-
August 10, 2026
0
Biotech
Verastem Oncology Reports $40.1 Million Q2 Revenue, Advances KRAS G12D Program
Life Sciences Times
-
August 7, 2026
0
Biotech
PepGen Reports $17.8 Million Q2 Loss as Higher-Dose DM1 Trial Advances
Life Sciences Times
-
August 6, 2026
0
Biotech
Sarepta Reports $401.3 Million in Q2 Revenue, Names Michael Severino CEO
Life Sciences Times
-
August 6, 2026
0
Biotech
Zai Lab Reports $50.8 Million Q2 Loss as Drug Pipeline Advances
Life Sciences Times
-
August 6, 2026
0
Biotech
Vedanta Biosciences Raises $60 Million to Advance Phase 3 C. Difficile Trial
Life Sciences Times
-
August 6, 2026
0
Biotech
Scholar Rock Reports $109.9 Million Q2 Loss as FDA Reviews SMA Drug
Life Sciences Times
-
August 6, 2026
0
Biotech
Precision BioSciences Reports $32.7 Million Q2 Loss, Advances Gene-Editing Trials
Life Sciences Times
-
August 6, 2026
0
Biotech
Viridian Posts $127.1 Million Q2 Loss After Launching Thyroid Eye Disease Drug
Life Sciences Times
-
August 6, 2026
0
Biotech
Agenus Reports $34.5 Million in Q2 Revenue, Advances Phase 3 Colon Cancer Trial
Life Sciences Times
-
August 6, 2026
0
Biotech
Expedition Therapeutics Raises $115 Million, Begins Phase 2 COPD Trial
Life Sciences Times
-
August 5, 2026
0
1
2
3
...
107
Page 2 of 107
Most Read
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
August 18, 2026
Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer
August 18, 2026
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
August 18, 2026
Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs
August 18, 2026